Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

10 Jun 2015 07:00

RNS Number : 7003P
Sopheon PLC
10 June 2015
 

SOPHEON PLC

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon plc, the international provider of software and services that help organizations generate more revenues and profits from new products, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"We entered 2014 on the back of the strongest quarter in our history, and having taken the business from under $13m revenues in 2009, to almost $21m in 2013. This advance was coupled with steady improvements in profitability. We also entered 2014 in the middle of a strategic transition moving beyond delivering process automation, to delivering integrated, enterprise class innovation management solutions. We made substantial progress in 2014 completing this shift in our business model whilst also remaining EBITDA profitable.

 

We added ten new customers in the year - across a broad range of industries. We completed the expansion and transformation in our sales organization, under the leadership of Sheila Plunkett in the US and Pieter Leijten in Europe. Our services organization was also restructured to support our growth strategy, and furthermore, we have brought services, support and development under the common leadership of Don Sarno as chief operating officer.

 

Ongoing investment in software development delivered a continued rapid pace of releases, with Accolade 9.1, 9.2 and 9.3 released in April, September and February respectively, and a major 10.0 release announced in early June. We continue to bring forward new and unique functionality. As well as a host of functional enhancements in roadmapping, resource planning and project execution, we have also extended security, integration and have introduced a new user experience through a "personalized interface" - bringing increased agility to the customer, while meeting the needs of new vertical segments as well as enterprise class requirements.

 

Further, we have introduced Accolade Express, to enable rapid improvement of customers' innovation performance, by implementing out-of-the-box best practices content developed from over a decade of experience with industry leaders. Speed to value through digitization is an increasing need for corporations. By way of example, in early May Vesuvius, a new Sopheon customer, reported beating their rollout timetable and achieving a high adoption of their Stage-Gate process - enabled by Accolade Express across multiple business units - and went from purchase in September 2014 to going live in December. Their innovation team spans four global sites and 300 cross-functional people, with several business units having 100% of their projects in the system.

 

As we announced towards the end of 2014, a number of large transactions were delayed into 2015. We continue to work on all these opportunities. Such delays often reflect growth in size and scale; a number of such opportunities - with both new and existing customers - are anticipated to come through in Q3 2015 and accordingly, we expect that revenues for 2015 will be significantly weighted to the second half. Full year revenue visibility, from contracted business and recurring revenue streams,today stands at $12.5m. We continue to apply new selling models with the ambition to reduce the lengthy sales process. Sopheon leads the market for innovation management solutions, with a breadth of vision, experience and capability that is unmatched by competitors that have emerged in recent years.

 

Early in 2014, $3.5m in new debt facilities were agreed with Silicon Valley Bank and since then we have continued to deepen our relationship with this well-known technology focused financial partner. In December 2014, we successfully completed the share consolidation and capital reduction process initiated the year before, with a cumulative reduction of very small shareholdings by approximately 10,000 across the UK and the Netherlands. More recently, following Euronext's decision to close its Alternext Amsterdam segment, the board decided to consolidate the Company's listing on AIM where Sopheon will remain accessible to the Dutch investment community. Accordingly, Sopheon delisted from Amsterdam in early May 2015. During both the share consolidation and the delisting periods, the board stood behind the Company's shares and purchased the equivalent of 808,833 ordinary shares, underscoring its belief in the business.

 

We continue to anticipate and position the business for improved commercial progress, to match and leverage the major strides made with product, organizational, and corporate matters."

 

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1276 919 560

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Ed Frisby / Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

Tim Thompson / Edward Treadwell

Newgate

+ 44 (0) 20 7653 9850

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFFTRIIAIIE
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.